Evolutionary Genomics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Evolutionary Genomics generated cash of -$640,947, which is more than the previous year. Cash used in financing activities reached the amount of $1,004,004 last year. Net change in cash is therefore $363,057.
Cash Flow
| 2013 | -13.16K | 0 | 13.69K |
|---|---|---|---|
| 2014 | -25.80K | -1.46K | 25.16K |
| 2015 | -590.04K | 134.28K | 0 |
| 2016 | -1.10M | 156.13K | 3.00M |
| 2017 | -1.17M | 0 | -242.36K |
| 2018 | -748.83K | 0 | -242.36K |
| 2019 | -625.98K | 0 | 540.01K |
| 2020 | -2.29M | 147.61K | 2.32M |
| 2021 | -1.58M | 0 | 1.58M |
| 2022 | -640.94K | 0 | 1.00M |
FNAM Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 214.00K | 215.83K | 45.44K | 131.40K | 880.24K | 2.05M | 3.82K | 459.58K | 641 | 114 |
Operating activities | ||||||||||
Net income | -1.93M | -2.79M | -1.71M | -793.14K | -1.09M | -539.61K | -1.15M | -285.99K | -27.13K | -19.26K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.02M | 1.03M | 409.36K | 40.72K | 41.07K | 42.85K | 38.89K | 28.11K | 10 | 0 |
Stock-based compensation expense | 193.20K | 219.71K | 219.71K | 55.82K | 0 | 101.89K | 101.84K | 8.92K | 90 | 0 |
| Deferred income tax benefit | 193.20K | 219.71K | 219.71K | 55.82K | 0 | 101.89K | 101.84K | 8.92K | 90 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 6.84K | 33.59K | -40.43K | 9.28K | 6.85K | 24.48K | 83 | 0 |
Inventories | 0 | 0 | 16.25K | -19.41K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 159.37K | 15.70K | -16.25K | 19.41K | -10.64K | -35.42K | -93.78K | 80.35K | -1.65K | 0 |
Cash generated by operating activities | -640.94K | -1.58M | -2.29M | -625.98K | -748.83K | -1.17M | -1.10M | -590.04K | -25.80K | -13.16K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -3 | 0 | 0 | 0 | 0 | 0 | -103.19K | 0 | -163 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 82.02K | -255 | 0 |
Cash generated by investing activities | 0 | 0 | 147.61K | 0 | 0 | 0 | 156.13K | 134.28K | -1.46K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 550K | 0 | 0 | 540.01K | 0 | 0 | 3.00M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -242.36K | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -1.58M | -2.32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 1.00M | 1.58M | 2.32M | 540.01K | -242.36K | -242.36K | 3.00M | 0 | 25.16K | 13.69K |
Net Change In Cash | 363.05K | -1.82K | 170.39K | -85.96K | -748.83K | -1.17M | 2.05M | -455.76K | -181 | 527 |
Cash at end of period | 577.06K | 214.00K | 215.83K | 45.44K | 131.40K | 880.24K | 2.05M | 3.82K | 459 | 641 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |